RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재후보

    하시모토 갑상선염과 갑상선유두암 = Hashimoto's Thyroiditis and Papillary Thyroid Cancer

    한글로보기

    https://www.riss.kr/link?id=A101591082

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    The association of Hashimoto’s thyroiditis (HT) with papillary thyroid cancer (PTC) has been still under debate.
    Some suggest that these two are positively correlated, whereas other studies report no relationship. We performed a systematic literature review of original studies to investigate the correlation between HT and PTC.
    The existing data provide inconsistent evidence favoring a causal relationship between HT and PTC. The average prevalence rate of PTC in patients with HT was 1.2% in 8 fine needle aspiration (FNA) studies of 18,023 specimens and 27.6% in 8 archival thyroidectomy studies of 9884 specimens. The risk ratio of PTC in HT specimens ranged from 0.39 to 1.00 in the FNA group (average RR 0.69) in contrast to 1.15 to 4.16 from thyroidectomy studies (average RR 1.59). Population-based fine needle aspiration biopsy studies report no relationship, whereas many of the studies using thyroidectomy specimens report a positive relationship, possibly related to selection bias. Several studies identified a few biomolecular markers, including the PI3K/Akt pathway, RET/PTC gene rearrangements, p63 protein, and loss of heterozygosity of hOGG1, that are potentially involved in neoplastic transformation from HT to PTC. So far, no causal genetic linkage has been confirmed. PTC with concurrent HT is associated with female gender, young age, less aggressive disease such as small tumor size, less frequent capsular invasion and nodal metastasis, and better outcome. However, more prospective studies with long term follow-up are needed to further elucidate this relationship and prognosis. Careful observation and follow-up of HT patients is recommended, especially those with nodular variants.
    번역하기

    The association of Hashimoto’s thyroiditis (HT) with papillary thyroid cancer (PTC) has been still under debate. Some suggest that these two are positively correlated, whereas other studies report no relationship. We performed a systematic literatur...

    The association of Hashimoto’s thyroiditis (HT) with papillary thyroid cancer (PTC) has been still under debate.
    Some suggest that these two are positively correlated, whereas other studies report no relationship. We performed a systematic literature review of original studies to investigate the correlation between HT and PTC.
    The existing data provide inconsistent evidence favoring a causal relationship between HT and PTC. The average prevalence rate of PTC in patients with HT was 1.2% in 8 fine needle aspiration (FNA) studies of 18,023 specimens and 27.6% in 8 archival thyroidectomy studies of 9884 specimens. The risk ratio of PTC in HT specimens ranged from 0.39 to 1.00 in the FNA group (average RR 0.69) in contrast to 1.15 to 4.16 from thyroidectomy studies (average RR 1.59). Population-based fine needle aspiration biopsy studies report no relationship, whereas many of the studies using thyroidectomy specimens report a positive relationship, possibly related to selection bias. Several studies identified a few biomolecular markers, including the PI3K/Akt pathway, RET/PTC gene rearrangements, p63 protein, and loss of heterozygosity of hOGG1, that are potentially involved in neoplastic transformation from HT to PTC. So far, no causal genetic linkage has been confirmed. PTC with concurrent HT is associated with female gender, young age, less aggressive disease such as small tumor size, less frequent capsular invasion and nodal metastasis, and better outcome. However, more prospective studies with long term follow-up are needed to further elucidate this relationship and prognosis. Careful observation and follow-up of HT patients is recommended, especially those with nodular variants.

    더보기

    참고문헌 (Reference)

    1 Kurukahvecioglu O, "Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma" 24 (24): 510-516, 2007

    2 McLeod DS, "Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis" 97 (97): 2682-2692, 2012

    3 Shih ML, "Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers" 18 (18): 729-734, 2008

    4 Muzza M, "The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies" 72 (72): 702-708, 2010

    5 Ott RA, "The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules" 98 (98): 1202-1206, 1985

    6 Tamimi DM, "The association between chronic lymphocytic thyroiditis and thyroid tumors" 10 (10): 141-146, 2002

    7 Crile G Jr, "Struma lymphomatosa and carcinoma of the thyroid" 147 (147): 350-352, 1978

    8 Dailey ME, "Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland" 70 (70): 291-297, 1955

    9 Salmaso C, "Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves'disease" 966 : 496-501, 2002

    10 Siriweera EH, "Profile of Hashimoto's thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto's thyroiditis?" 2010 : 124264-, 2010

    1 Kurukahvecioglu O, "Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma" 24 (24): 510-516, 2007

    2 McLeod DS, "Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis" 97 (97): 2682-2692, 2012

    3 Shih ML, "Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers" 18 (18): 729-734, 2008

    4 Muzza M, "The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies" 72 (72): 702-708, 2010

    5 Ott RA, "The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules" 98 (98): 1202-1206, 1985

    6 Tamimi DM, "The association between chronic lymphocytic thyroiditis and thyroid tumors" 10 (10): 141-146, 2002

    7 Crile G Jr, "Struma lymphomatosa and carcinoma of the thyroid" 147 (147): 350-352, 1978

    8 Dailey ME, "Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland" 70 (70): 291-297, 1955

    9 Salmaso C, "Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves'disease" 966 : 496-501, 2002

    10 Siriweera EH, "Profile of Hashimoto's thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto's thyroiditis?" 2010 : 124264-, 2010

    11 Mukasa K, "Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases" 21 (21): 37-41, 2011

    12 Mechler C, "Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements" 85 (85): 1831-1837, 2001

    13 Repplinger D, "Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?" 150 (150): 49-52, 2008

    14 Todd I, "Interferon-gamma induces HLA-DR expression by thyroid epithelium" 61 (61): 265-273, 1985

    15 Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002" 295 (295): 2164-2167, 2006

    16 Larson SD, "Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway" 204 (204): 764-773, 2007

    17 Bradly DP, "Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases" 146 (146): 1099-1104, 2009

    18 Carson HJ, "Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study" 14 (14): 38-42, 1996

    19 Crile G Jr, "Incidence of cancer in struma lymphomatosa" 115 : 101-103, 1962

    20 Anil C, "Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study" 20 (20): 601-606, 2010

    21 Lun Y, "Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis" 148 (148): 396-402, 2013

    22 Anderson L, "Hashimoto thyroiditis: Part 2, sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis" 195 (195): 216-222, 2010

    23 Cipolla C, "Hashimoto thyroiditis coexistent with papillary thyroid carcinoma" (10) : 874-878, 2005

    24 Royer MC, "Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity" 136 (136): 240-242, 2010

    25 Unger P, "Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?" 34 (34): 764-, 2003

    26 Dvorkin S, "Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis" 98 (98): 2409-2414, 2013

    27 Erdogan M, "Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey" 36 (36): 486-490, 2009

    28 Kebebew E, "Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited" 25 (25): 632-637, 2001

    29 Singh B, "Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome" 126 (126): 1070-1076, 1999

    30 Matesa-Anic D, "Coexistence of papillary carcinoma and Hashimoto's thyroiditis" 48 (48): 9-12, 2009

    31 Mazokopakis EE, "Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study" 9 (9): 312-317, 2010

    32 정준수, "Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome" 대한의학회 27 (27): 883-889, 2012

    33 Spencer CA, "Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC)" 96 (96): 3615-3627, 2011

    34 Dayan CM, "Chronic autoimmune thyroiditis" 335 (335): 99-107, 1996

    35 Holm LE, "Cancer risks in patients with chronic lymphocytic thyroiditis" 312 (312): 601-604, 1985

    36 Hanafusa T, "Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity" 2 (2): 1111-1115, 1983

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2027 평가 재인증평가 신청대상 (재인증)
    2021-01-01 등재 등재학술지 유지 (재인증) KCI등재
    2018-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2015-12-14 학술지명변경 한글명 : 대한갑상선학회지 -> International Journal of Thyroidology
    외국어명 : Clinical and Experimental Thyroidology -> International Journal of Thyroidology
    KCI등재
    2015-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2014-11-04 학술지명변경 외국어명 : Journal of Korean Thyroid Association -> Clinical and Experimental Thyroidology KCI등재후보
    2013-01-01 등재 등재후보 1차 FAIL (등재후보1차) KCI등재후보
    2011-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.08 0.08 0.13
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.14 0.13 0.355 0
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼